We have seen an increase in lawsuits over the way that standard-essential patents are used and enforced.
Industry standards are critical to innovation and new technologies, products, and services.
Consumers like competition, interoperability, and choice with respect to their devices.
This is a very important hearing that we're having to learn more about pay-for-delay agreements.
We should be doing all we can to see that the American consumer has access to lower-priced drugs.
I think they harm drug competition.
The reality is that these deals between brand-name and generic pharmaceutical companies delay the entry of generic medic...
In my opinion, they only end up keeping drug costs artificially high for consumers and the taxpaying public.
According to the 2010 Federal Trade Commission report entitled 'Pay For Delay: How Drug Companies Payoffs Cost Consumers...
I worked hard to make sure that this notice and filing provision was included in that legislation.
the 340B program is not intended to subsidize pharmacies that team up with covered entities to turn a profit.